The surgical complications of Ehlers-Danlos syndrome
Abstract
Between January 1975 and July 1995, 44 gastrointestinal and 45 vascular complications of Ehlers-Danlos syndrome type IV (EDS-IV) were reported in the literature. This included 41 colon perforations, 2 paraesophageal hernias, 22 spontaneous hemorrhages, 17 aneurysms, and 5 arterial dissections. Twenty-seven colonic perforations were treated with resection and diversion, 11 with total abdominal colectomy (TAC), and 3 with primary colon repair. Reperforation occurred in 15 resection/diversion patients versus none treated with TAC (P < 0.05). Seven patients (23.3%) died from their gastrointestinal complications. Eleven vascular complications were treated with nonoperative management, eight with vessel ligation, 20 with arterial reconstruction, and two with therapeutic angiography. Eighteen patients underwent angiography, with three (22%) major complications and one death (5.6%). Twelve (30%) patients died from vascular complications of EDS-IV, seven of whom had been treated with arterial reconstruction (P < 0.05). This review supports treating colon perforations in EDS-IV patients with TAC and end ileostomy to avoid a reperforation or an anastamotic leak. EDS-IV patients with vascular complications should be treated with nonoperative therapy and noninvasive imaging techniques when possible. Operative intervention, when required, should focus on simple vessel ligation rather than reconstruction.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.